These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 32958825)
41. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells. Kim W; Youn H; Kang C; Youn B Apoptosis; 2015 Sep; 20(9):1242-52. PubMed ID: 26033480 [TBL] [Abstract][Full Text] [Related]
42. Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism. Hou XB; Li TH; Ren ZP; Liu Y Biomed Pharmacother; 2016 Dec; 84():1575-1584. PubMed ID: 27825799 [TBL] [Abstract][Full Text] [Related]
43. TGFβ can stimulate the p(38)/β-catenin/PPARγ signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells). Lin LC; Hsu SL; Wu CL; Hsueh CM Clin Exp Metastasis; 2014 Dec; 31(8):881-95. PubMed ID: 25168821 [TBL] [Abstract][Full Text] [Related]
44. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer. Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892 [TBL] [Abstract][Full Text] [Related]
45. Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer. Ferrarotto R; Goonatilake R; Yoo SY; Tong P; Giri U; Peng S; Minna J; Girard L; Wang Y; Wang L; Li L; Diao L; Peng DH; Gibbons DL; Glisson BS; Heymach JV; Wang J; Byers LA; Johnson FM Clin Cancer Res; 2016 Apr; 22(7):1674-1686. PubMed ID: 26597303 [TBL] [Abstract][Full Text] [Related]
46. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells. Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408 [TBL] [Abstract][Full Text] [Related]
47. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
48. 2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway. Schweikl H; Petzel C; Bolay C; Hiller KA; Buchalla W; Krifka S Biomaterials; 2014 Mar; 35(9):2890-904. PubMed ID: 24411679 [TBL] [Abstract][Full Text] [Related]
49. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status. Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439 [TBL] [Abstract][Full Text] [Related]
50. Bavachinin exhibits antitumor activity against non‑small cell lung cancer by targeting PPARγ. Ge LN; Yan L; Li C; Cheng K Mol Med Rep; 2019 Sep; 20(3):2805-2811. PubMed ID: 31322235 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs. Ahmad A; Maitah MY; Ginnebaugh KR; Li Y; Bao B; Gadgeel SM; Sarkar FH J Hematol Oncol; 2013 Oct; 6(1):77. PubMed ID: 24199791 [TBL] [Abstract][Full Text] [Related]
52. Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function. Liu ZJ; Liu HQ; Xiao C; Fan HZ; Huang Q; Liu YH; Wang Y J Neurosci Res; 2014 Nov; 92(11):1549-59. PubMed ID: 24975470 [TBL] [Abstract][Full Text] [Related]
53. Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest. Kriegs M; Gurtner K; Can Y; Brammer I; Rieckmann T; Oertel R; Wysocki M; Dorniok F; Gal A; Grob TJ; Laban S; Kasten-Pisula U; Petersen C; Baumann M; Krause M; Dikomey E Radiother Oncol; 2015 Apr; 115(1):120-7. PubMed ID: 25796091 [TBL] [Abstract][Full Text] [Related]
54. Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway. Hong SW; Park NS; Noh MH; Shim JA; Ahn BN; Kim YS; Kim D; Lee HK; Hur DY Lung Cancer; 2017 Apr; 106():115-124. PubMed ID: 28285685 [TBL] [Abstract][Full Text] [Related]
55. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
56. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation. Bao L; Diao H; Dong N; Su X; Wang B; Mo Q; Yu H; Wang X; Chen C Cell Biol Toxicol; 2016 Dec; 32(6):469-482. PubMed ID: 27423454 [TBL] [Abstract][Full Text] [Related]
57. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy. To KKW; Wu WKK; Loong HHF Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193 [TBL] [Abstract][Full Text] [Related]
58. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure. Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297 [TBL] [Abstract][Full Text] [Related]
59. ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα. Sinha S; Ghildiyal R; Mehta VS; Sen E Cell Death Dis; 2013 May; 4(5):e615. PubMed ID: 23640457 [TBL] [Abstract][Full Text] [Related]
60. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death. Jung JY; Yoo CI; Kim HT; Kwon CH; Park JY; Kim YK Toxicology; 2007 May; 234(1-2):73-82. PubMed ID: 17363128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]